Navigation Links
Tecnalia has calculated the carbon footprint of some wines
Date:3/21/2013

In a highly detailed study, Tecnalia has calculated the carbon footprint of the Grupo Faustino's 8 most representative wines throughout their lifecycle; from the field work right up to the end of the bottle's useful life.

A wine's carbon footprint is the piece of information that allows one to know the quantity of greenhouse gases emitted during its production process. Tecnalia has enabled the Grupo Faustino to be the first winery to find out the carbon footprint of its eight most representative wines, following an exhaustive study, which is the first of its type in its field.

Tecnalia worked throughout 2012 on a detailed study for the Grupo Faustino winery. As a result, the carbon footprints have been obtained of the Group's eight most representative wines, which also constitute the whole range of wines in our country: white, vintage, reserve, signature, etc.

Tecnalia has analysed all the phases in the life cycle of the eight wines selected: agricultural phase (diesel consumed by journeys and tractor work in all the field tasks, consumption of agrochemicals, consumption of electrical power for irrigation, etc.); production phase (consumption of electrical power and heating oil, consumption of winemaking products and packaging materials, etc.); distribution phase (transporting of bottles); use phase (cooling of the bottles for consuming the wine); and finally, the end-of-life phase (management and transport of waste products, recycling, upgrading or landfill).

Unlike other studies carried out, it should be highlighted that the last 2 phases in the life cycle (use and end-of-life) have been taken into consideration and that no other winery group has calculated and certified its carbon footprint for such a large number of wines.

The results obtained by Tecnalia show that the carbon footprint of the eight Faustino wines analysed is within the range of values close to 1,000 grams of CO2-equivalent. According to the exper
'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2

Related biology news :

1. Neiker-Tecnalia identifies antitumour proteins in the latex of the plant Euphorbia trigona
2. AZTI-Tecnalia leads 2 research projects on bluefin tuna with 1.5 million euros investment
3. TECNALIA leads research to develop new biocomposites based on wheat straw and recycled paper
4. AZTI-Tecnalia is turning vegetable by-products destined for landfills into feedstuff
5. New Center for Carbon Measurement to drive UKs low carbon economy
6. Measuring our carbon footprint
7. Research on carbon-consuming life-forms in Antarctica published in JoVE
8. Time, place and how wood is used are factors in carbon emissions from deforestation
9. New study by WHOI scientists provides baseline measurements of carbon in Arctic Ocean
10. Seagrasses can store as much carbon as forests
11. Computer model pinpoints prime materials for efficient carbon capture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. today ... (FIDO ® ) Alliance tm , an industry ... members commit to share technology and collaborate to ... are interoperable, more secure and private, and easier ... identity verification that protects sensitive user information and ...
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... time in a restful state akin to hibernation rather than ... in cells, new research suggests. And instead of being ... restful period appears to be a programmed step for RNA ... cell division and decide where proteins will work in a ...
... Leuven scientists (VIB/KU Leuven) are using zebrafish as a model ... the mechanism of amyotrophic lateral sclerosis (ALS). As a result, ... for a future ALS treatment. ALS is a progressive degenerative ... Their study has been published in the prestigious journal ...
... have long been appreciated, but now scientists at Duke ... makes mother,s milk better than infant formula in protecting ... in the August issue of the journal Current ... but not infant formula, fosters colonies of microbiotic flora ...
Cached Biology News:To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 2To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 3To cap or not to cap: Scientists find new RNA phenomenon that challenges dogma 4Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis 2Breast milk promotes a different gut flora growth than infant formulas 2Breast milk promotes a different gut flora growth than infant formulas 3
(Date:4/30/2015)... YORK , April 30, 2015 The following ... Board of Directors of China Cord Blood Corp (NYSE: ... the special committee of the independent directors of China Cord ... low privatization offer of $6.40 per share from Golden Meditech ... at $6.40 per share would greatly benefit Golden Med and ...
(Date:4/30/2015)... April 30, 2015 - ... Biotechnology Company   Shire (LSE: SHP, ... three months to March 31, 2015. ... million +9% +13% Total revenues $1,488 million +11% +15% ... GAAP operating income from continuing operations $475 million +55% ...
(Date:4/30/2015)... (PRWEB) April 30, 2015 Clinovo ... 2015 PharmaSUG Annual Conference held in Orlando, FL ... Staffing Solutions along with Leslie Kolman, Manager of Staffing ... latest Clinovo news at Booth #17. , “We ... Conference again this year”, Says Trisha Heredia, Senior Director ...
(Date:4/29/2015)... , April 29, 2015   Doximity , the ... all US doctors as members, announced a new, instant ... "Apply Using Doximity." With one click, all US physicians ... curriculum vitae (CV) for an open job opportunity, and ... Eighty seven percent of physicians are open ...
Breaking Biology Technology:April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 2Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 3Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 4Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 5Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 6Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 7Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 8Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 9Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 10Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 11Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 12Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 13Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 14Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 15Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 16Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 17Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 18Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 19Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 20Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 21Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 22Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 23Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 24Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 25Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 26Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 27Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 28Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS 29Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 2Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 3Doximity Offering Hospitals Easy, Efficient Physician Application Tool 2
... Pearl Therapeutics, Inc.,a biopharmaceutical company developing treatments ... Colin Reisner, MD, FCCP,FAAAAI to the position of ... Development and Medical Affairs, and Michael Golden,to the ... "We are delighted to welcome Colin and ...
... New Clinical Trial Sites Recently Initiated To Support Ongoing ... Trials-, ... Including Four Phase II Trials in Major Disease Indications-, -Revenues Plus Cash On-Hand ... Advance ...
... HONG KONG, Dec. 20 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development ... a,provider of clean and renewable energy products and ... announced that it has completed,another step in its ... resources on the principal business of solar energy., ...
Cached Biology Technology:Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 2Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 4Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 5CTDC Announces the Disposal of Non-core Business 2
...
...
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
Biology Products: